For Myriad Genetics, the gene patent fight isn’t over yet

Whether sequences of genetic material can be patented has been a matter of heated debate for the past decade or more.

In many countries, patents have been granted for isolated gene sequences, methods of isolating sequences, methods of using sequences for diagnosing genetic diseases, and a whole range of other gene-related products and methods.

The US decision signalled the end of fears that patents could impede genetic research as well as the provision of diagnostic genetic tests. Or so many thought.

But the patent landscape around genetic testing for the BRCA genes is, in fact, far more complex than this.

Read the full, original story here: For Myriad Genetics, the gene patent fight isn’t over yet

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.